The preS1 antigen of hepatitis B virus is highly immunogenic at the T cell level in man.

14 hepatitis B vaccine recipients who showed high titers of anti-hepatitis B surface antibodies in serum after booster immunization with a polyvalent hepatitis B surface antigen vaccine that contained trace amounts of hepatitis B virus (HBV) preS1 and preS2 envelope antigens were studied for their i...

Celý popis

Podrobná bibliografie

Vydáno v:	J Clin Invest
Hlavní autoři:	Ferrari, C, Penna, A, Bertoletti, A, Cavalli, A, Valli, A, Schianchi, C, Fiaccadori, F
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Clinical Investigation 1989
Témata:	Research Article
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC329792/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2529268/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI114299
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!